Article and Video CATEGORIES
Chief of Hematology/Oncology and Medical Director at Memorial Cancer Institute, and Clinical Associate Professor of Medicine at Florida International University
Chief of Hematology/Oncology
Medical Director of Memorial Cancer Institute
TRANSCRIPTS - Spanish and English transcripts available soon
PDL1 como biomarcador para segundo tratamiento
PDL1 as a biomarker for second-line treatment
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
ONKTALK is tomorrow.
I hope to see you there.
The forum is now available on demand here. Don't hesitate to ask questions as they come up.
Take care,
Janine
Hi happybluesun, Welcome to Grace. I'm sorry your mom is going through this.
Driver mutations are mutations that drive (or cause) the cancer. Having more than one driver mutation is...
Hi happybluesun, How is your mom feeling? Her case has specific components including the rare combo of mutations situation we can't help with a specific "this is standard of care". She...